
HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd. (HIVE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HIVE · as of Jun 8, 2026
Key Statistics
Explore HIVE Digital Technologies Ltd. Data
hive stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The HIVE analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $6.42, representing +70.29% upside from the current price of $3.77.
Competitors & Peers
hive competitorsStock Performance
Full HistoryAbout HIVE Digital Technologies Ltd.
HIVE Digital Technologies Ltd. a technology company, engages in the building and operating data centers powered by green energy in Bermuda. The Company operates the mining and sale of digital currenc…
what is hive digital technologies ltd. · hive stock overview · hive digital technologies ltd. company profile · who is hive digital technologies ltd. ceo · hive NASDAQ · hive digital technologies ltd. headquarters · hive digital technologies ltd. business segments
About Stock Overview & Key Data
HIVE Digital Technologies Ltd. (HIVE) is a Financial Services company in the Information Technology Services industry, listed on NASDAQ since Feb 2, 2011. As of the latest trading session, HIVE stock price is $3.77, with a market capitalization of $1.0B. The stock has returned +87.56% over the past 12 months and +46.12% year-to-date.
According to 9 Wall Street analysts, the consensus rating for HIVE Digital Technologies Ltd. stock is Buy, with an average 12-month price target of $6.42. In fiscal year 2026, HIVE Digital Technologies Ltd. reported revenue of $297.8M and net income of -$148.4M. For detailed data — including HIVE Digital Technologies Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, HIVE Digital Technologies Ltd. (HIVE) stock price is $3.77. The stock is traded on NASDAQ under the ticker symbol HIVE. The 52-week range is $1.60 – $7.84.